Singapore HSA Medical Device Registration Services
Cisema delivers a comprehensive suite of regulatory and quality services for medical device and in-vitro diagnostic (IVD) manufacturers seeking to enter and grow in the Singapore market. With deep expertise in Health Sciences Authority (HSA) requirements and a fully licensed local presence, Cisema acts as your Local Authorized Representative (LAR), Marketing Authorization Holder (MAH), or embedded regulatory team—guiding you through every phase of the product lifecycle.
What Sets Cisema Apart in Singapore Medical Device Registration?
At Cisema, our value goes far beyond regulatory submissions. We provide an integrated, strategy-driven framework tailored to the demands of the Singapore market:
We provide you more than just data; we provide the insights you need to navigate Singapore’s intricate regulatory shifts and emerging market trends. By focusing on the real-time dynamics of the market, we empower you to anticipate policy changes, understand regional complexities, and make decisions with confidence – Staying ahead in a market where the rules are constantly being rewritten.
Retain complete control over your product registration and distributor relationships through our independent MAH/LAR model.
Custom guidance for all classes of devices (B, C, D) and complex product types, including combination devices.
From registration to post-approval variations, renewals, and incident reporting—we stay with you throughout.
Stay ahead of evolving HSA requirements and ASEAN harmonization with regular updates and risk impact assessments.
ISO 13485 gap analysis, SOP development, and local QMS implementation support.
Launch and maintain your product across Southeast Asia with one cohesive, multi-country partner.
Evaluate market potential and regulatory readiness before initiating registration.
Our Core Regulatory Services in Singapore
We provide full-spectrum regualtory services in Singapore, from local authorized representative support to HSA submission and post-market compliance, helping manufacturers enter and scale in one of Asia’s most regulated markets.
Local Authorized Representative
License Holding: LAR / MAH Representation
- Legally represent your device with the HSA
- Direct communication channel with authorities
- Flexible distributor listing without lock-in
- Ensure compliance with Singapore’s HSA requirements
Regulatory Strategy & Classification Advisory
- Risk class determination under HSA rules (B, C, D)
- Qualification as a medical device or IVD
- Regulatory roadmap and documentation readiness planning
Medical Device Registration
Dossier Preparation & Submission
- ASEAN CSDT and Singapore-specific formatting
- Localization and translation of IFUs, labels, and technical files
- Submission via the HSA’s MEDICS system
- Real-time tracking and communication during evaluation
Post-Approval Compliance Management
- Change management (label, site, product changes)
- Registration renewals and variations
- Vigilance, adverse event reporting, FSCA coordination
Cosmetic Regulation Service
License Holding & PRISM Notification
- Neutral Independent Notification Holder (INH)
- No import/distribution activities – you control partners
- Preparation and submission via HSA’s PRISM system
Compliance & Ongoing Support
- Ingredient safety review against ASEAN Annexes
- Label validation per ACD requirements and claims review
- Importer/distributor listing and coordination
- Post-market surveillance, recalls & regulatory updates
Quality Control Inspection Service
On-Site Inspections & Sampling
- Incoming goods quantity and label check
- Pre-shipment visual and functional inspection
- AQL sampling and in-process defect control
- Container loading verification and supervision
Audit Readiness & Supplier Oversight
- Factory audits aligned with ISO 13485
- Returned goods and FSCA inspection support
- Audit preparation for HSA and regulators
Singapore's HSA Medical Device Regulatory Framework
In the Singapore medical device regulatory framework, Class A devices, which are considered low-risk, are exempt from full registration. However, they must still meet safety and performance requirements and must comply with labeling standards.
| Country | Device Classes | LAR Required | Avg. Approval Timeline | License Holding | Post-Market Support |
|---|---|---|---|---|---|
| Singapore | Class B–D | Yes | 5 – 12 months | Yes | Yes |
Our Singapore Medical Device Regisrtation Services Area Ideal for Companies That:
- Require independent regulatory representation in Singapore
- Seek multi-country ASEAN expansion with consistent oversight
- Want control over pricing, distribution, and license ownership
- Develop complex or high-risk devices needing expert guidance
- Prefer a strategic regulatory partner, not a transactional filing agent
Why Partner with Cisema for Singapore Medical Device Registration?
Accelerate Market Entry in China and Southeast Asia with Proven Expertise
With more than two decades of experience, Cisema is your trusted partner for navigating China’s complex NMPA system and accelerating access to ASEAN markets. Our licensed local presence in Malaysia, Singapore, Vietnam, Indonesia, the Philippines, and Thailand ensures you benefit from seamless regional coordination and faster approvals.
Real-World Insights to Drive Your Success Across Borders
We go beyond theory—our bilingual teams work daily with regulators in China and across Southeast Asia to deliver insights you can act on. From classification and dossier strategy to post-market compliance, we help you anticipate regulatory changes and respond with confidence.
Tailored Strategies for Multi-Market Success
Every market is different—so your approach should be too. Whether launching in China or planning a multi-country ASEAN rollout, we tailor your regulatory roadmap to balance local requirements, timelines, and commercial needs, ensuring long-term success and flexibility.
Key Data for Entering the Singapore Medical Device Market
Singapore is a leading hub for medical technology in Southeast Asia, offering a transparent regulatory framework, a highly educated workforce, and strong IP protections. Below is a snapshot of essential data to help guide market entry and regulatory strategy.
| Data Category | Details |
|---|---|
| Market Size | Approximately SGD 1.5 billion in 2022, projected growth of 6% annually.[1] |
| Population | 5.6 million, with 16% aged 65 and older.[2] |
| Healthcare Facilities | Approximately 1,200 healthcare facilities, including 40 hospitals.[3] |
| Regulatory Authority | Health Sciences Authority (HSA) oversees medical device registration. |
| Healthcare Expenditure | Healthcare expenditure at 4.5% of GDP.[4] |
| GDP | USD 502 billion (2023).[5] |
[1] Singapore Medical Technology Industry Report, Singapore Economic Development Board (EDB).
[2] Singapore Department of Statistics, Population Trends 2022.
[3] Ministry of Health, Singapore, Annual Health Services Report.
[4] World Bank, Healthcare Expenditure Data for Singapore.
[5] World Bank, Singapore GDP 2023 Estimate.